Heparin-binding epidermal growth factor-like growth factor: P91 activation, induction of plasminogen activator plasminogen activator inhibitor, and tubular morphogenesis in human microvascular endothelial cells

被引:29
作者
Ushiro, S [1 ]
Ono, M [1 ]
Izumi, H [1 ]
Kohno, K [1 ]
Taniguchi, N [1 ]
Higashiyama, S [1 ]
Kuwano, M [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT BIOCHEM,SUITA,OSAKA 565,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1996年 / 87卷 / 01期
关键词
angiogenesis; human microvascular endothelial cell; HB-EGF; p91; t-PA;
D O I
10.1111/j.1349-7006.1996.tb00202.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidermal growth factor (EGF) or transforming growth factor-alpha (TGF-alpha) stimulates cell migration, proliferation and the formation of tube-like structures of human microvascular endothelial cells in culture. Heparin-binding EGF-like growth factor (HB-EGF), which shows 35% homology with EGF/TGF-alpha, is a member of the EGF family, and it is ubiquitous in many tissues and organs. We examined whether or not HB-EGF induced angiogenic responses in human microvascular endothelial cells, HB-EGF inhibited the binding of I-125-EGF to the EGF receptor and induced autophosphorylation of the receptor on endothelial cells. Exogenous HB-EGF induced the loss of more than 70% of the EGF receptor from the cell surface within 30 min, with similar kinetics to that of EGF, The level of c-fos mRNA markedly increased at 30 min in response to HB-EGF as well as EGF, A gel shift assay demonstrated the activation of the transcription factor p91 by HB-EGF and EGF, This factor directly interacts with the EGF receptor and mediates the activation of c-fos gene promoter. HB-EGF enhanced the mRNA expression of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) mRNA. However, the enhancement of t-PA and PAI-1 by HB-EGF was less than that by EGF, Heparitinase/chlorate, which digests the heparan sulfate proteoglycan of the endothelial cell surface, restored both t-PA and PAI-1 mRNA levels in response to HB-EGF in a manner similar to that by EGF. HB-EGF at 10 ng/ml developed tube-like structures in type I collagen gel at similar levels to that of EGF at 10 ng/ml, suggesting that HB-EGF is also a potent angiogenic factor in the model system for angiogenesis. The tubulogenesis activity of HB-EGF is discussed in relation to the expression of the t-PA and PAI-1 genes.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 55 条
[1]   INDUCTION OF VASCULAR ENDOTHELIAL TUBULAR MORPHOGENESIS BY HUMAN GLIOMA-CELLS - A MODEL SYSTEM FOR TUMOR ANGIOGENESIS [J].
ABE, T ;
OKAMURA, K ;
ONO, M ;
KOHNO, K ;
MORI, T ;
HORI, S ;
KUWANO, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :54-61
[2]   HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR - CHARACTERIZATION OF RAT AND MOUSE CDNA CLONES, PROTEIN DOMAIN CONSERVATION ACROSS SPECIES, AND TRANSCRIPT EXPRESSION IN TISSUES [J].
ABRAHAM, JA ;
DAMM, D ;
BAJARDI, A ;
MILLER, J ;
KLAGSBRUN, M ;
EZEKOWITZ, RAB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (01) :125-133
[3]   INTERACTION OF VASCULOTROPIN VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR WITH HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - BINDING, INTERNALIZATION, DEGRADATION, AND BIOLOGICAL EFFECTS [J].
BIKFALVI, A ;
SAUZEAU, C ;
MOUKADIRI, H ;
MACLOUF, J ;
BUSSO, N ;
BRYCKAERT, M ;
PLOUET, J ;
TOBELEM, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 149 (01) :50-59
[4]  
CARPENTER G, 1990, J BIOL CHEM, V265, P7709
[5]  
DLUZ SM, 1993, J BIOL CHEM, V268, P18330
[6]   TRANSCRIPTION FACTOR P91 INTERACTS WITH THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND MEDIATES ACTIVATION OF THE C-FOS GENE PROMOTER [J].
FU, XY ;
ZHANG, JJ .
CELL, 1993, 74 (06) :1135-1145
[7]   HUMAN 72-KILODALTON TYPE-IV COLLAGENASE FORMS A COMPLEX WITH A TISSUE INHIBITOR OF METALLOPROTEASES DESIGNATED TIMP-2 [J].
GOLDBERG, GI ;
MARMER, BL ;
GRANT, GA ;
EISEN, AZ ;
WILHELM, S ;
HE, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8207-8211
[8]   ANGIOGENIC ACTIVITY OF THE FIBROBLAST AND EPIDERMAL GROWTH-FACTOR [J].
GOSPODAROWICZ, D ;
BIALECKI, H ;
THAKRAL, TK .
EXPERIMENTAL EYE RESEARCH, 1979, 28 (05) :501-514
[9]  
HAMANAKA R, 1992, J BIOL CHEM, V267, P13160
[10]  
HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060